COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation
I. Tsimafeyeu,
G. Alekseeva,
M. Berkut,
A. Nosov,
I. Myslevtsev,
A. Andrianov,
A. Semenov,
P. Borisov,
R. Zukov,
V. Goutnik,
S. Savchuk,
M. Volkova,
M. Mukhina,
I. Tsimafeyeu
Institute of Oncology, Hadassah Medical Moscow, Moscow, Russian Federation
G. Alekseeva
Kidney Cancer Research Bureau, Moscow, Russian Federation
M. Berkut
Pacific State Medical University, Vladivostok, Russian Federation
A. Nosov
FSBI “N.N. Petrov NMRC of Oncology” of the Ministry Healthcare of the Russian Federation, St Petersburg, Russian Federation
I. Myslevtsev
St Alexei Central Clinical Hospital, Moscow, Russian Federation
A. Andrianov
Ivanovo Regional Oncology Dispensary, Ivanovo, Russian Federation
A. Semenov
V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation
P. Borisov
Medicine 24/7 Clinic, Moscow, Russian Federation
R. Zukov
Saint-Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological), St Petersburg, Russian Federation
V. Goutnik
N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation
S. Savchuk
Pfizer Innovations, Moscow, Russian Federation